Form 4: ACM Research CEO David Wang Sells Shares Under 10b5-1 Trading Plan

ACM Research CEO David Wang sold a total of 56,250 shares of Class A Common Stock in multiple transactions under a pre-arranged 10b5-1 trading plan.

Summary

• David H. Wang, CEO of ACM Research, sold 46,766 shares of Class A Common Stock at a weighted average price of $17.80 per share.
• He also sold an additional 9,484 shares of Class A Common Stock at a weighted average price of $18.31 per share.
• These sales were executed on November 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.
• The trading plan was initially adopted on May 14, 2024, and amended on August 13, 2024.
• Following these transactions, Mr. Wang directly owns 654,256 shares of Class A Common Stock.
• Mr. Wang also indirectly owns shares through various family trusts and his wife and daughter.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to insider trading under a pre-arranged plan. It doesn't indicate any positive or negative sentiment.

Risks

• Sales by insiders, even under a pre-arranged plan, can sometimes be perceived negatively by the market.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

• Many executives at publicly traded companies use 10b5-1 trading plans to sell shares, so this activity is not unusual.
• The volume of shares sold is not particularly large compared to the total outstanding shares of ACM Research.
• Comparable companies such as Lam Research and Applied Materials also see similar filings from their executives.

Stakeholder Impact

• The stock sales may have a minor impact on the share price, but the transactions were pre-planned and are not indicative of a change in the company's outlook.

Key Dates

Keywords

ACM Research, David Wang, insider trading, stock sale, Form 4, Rule 10b5-1, share transaction